Prognostic assessment in Stage I ovarian cancer using a discriminant analysis with clinicopathological and DNA flow cytometric data, Gynecol. Obstet. Invest. 27, 213-216 (1989).Punnonen R, Kallioniemi OP, Mattila J , Koivula T: Prognostic assessment in stage 1 ovarian cancer using a ...
A prognostic regulatory pathway in stage I Epithelial Ovarian Cancer: new hints for the poor prognosis assessment. Ann Oncol 2016;27:1511-9.Calura, E.L.; Paracchini, L.R.; Fruscio, R.A.; DiFeo, A.; Ravaggi, A.; Peronne, J.; Martini, P.; Sales, G.; Beltrame, L.; Bignotti...
Stage III: Cancer has spread to pelvic organs and possibly to lymph nodes. Microscopic "seeds" of cancer are on abdominal peritoneal surfaces (IIIA), or small implants of tumor on abdominal peritoneal surfaces (IIIB). Abdominal implants may be larger or lymph nodes may be involved (IIIC). St...
PurposeThe stage of disease is one of the strongest prognostic factors in epithelial ovarian cancer. The International Federation of Gynecology and Obstetrics (FIGO) classification was revised in 2013; stage IC was subdivided into IC1 (intraoperative surgical spill), IC2 (capsule rupture before surger...
The majority of Mater patients (72%) had either stage I or stage II ovarian cancer which is at variance with other studies and may reflect an under-staging at initial laparotomy. Their survival rates were better than those of the STR, probably because they had presented earlier and had a ...
a precursor lesion of ovarian cancer. In spite of favourable characteristics of EAOC, there was no difference in prognosis between EAOC and non-EAOC when adjusted with stage and a specific histology that suggests that endometriosis may not affect the progression after the onset of ovarian cancer...
Ovarian cancer (OC) is the second most common gynecological malignancy and the fifth leading cause of death due to cancer in women in the United States. These statistics reflect mainly the late-stage diagnosis and poor prognosis of OC1,2,3. Ovarian cancer consists of two major types: Type ...
Journal of Ovarian Research (2019) 12:112 https://doi.org/10.1186/s13048-019-0590-5 RESEARCH Open Access Thy-1 predicts poor prognosis and is associated with self-renewal in ovarian cancer Elizabeth V. Connor1,2* , Caner Saygin3, Chad Braley3,4, Andrew C. Wiechert1, Sheelarani Karuna...
被引量: 1发表: 2015年 Effect of different treatment modalities on the prognosis of stage IV epithelial ovarian cancer: analysis of the SEER database The prognosis of advanced ovarian cancer is often poor. Although there are several treatment options for stage IV epithelial ovarian cancer, it is...
CONCLUSION: On the basis of current retrospective evidence, the present meta-analysis indicated that high level of CD133 expression trends to correlate with a worse prognosis in patients with ovarian cancer. 展开 关键词: Ovarian cancer, cancer stem cells, CD133, prognosis ...